Search

Your search keyword '"Piotr, Kuna"' showing total 279 results

Search Constraints

Start Over You searched for: Author "Piotr, Kuna" Remove constraint Author: "Piotr, Kuna" Topic business.industry Remove constraint Topic: business.industry
279 results on '"Piotr, Kuna"'

Search Results

1. Management of anaphylaxis due to COVID-19 vaccines in the elderly

2. House dust mite sensitization and frequent antibiotic courses may suppress remission of rhinosinusitis and asthma symptoms in young children

3. Relationship between CCR5+FoxP3+ Treg cells and forced expiratory volume in 1 s, peak expiratory flow in patients with severe asthma

4. COVID-19 pandemic

5. A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma

6. Recommendations of the Polish Society of Allergology on the qualification of person with allergies and anaphylaxis to vaccination against COVID-19

7. Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial

8. Upper‐airway dysbiosis related to frequent sweets consumption increases the risk of asthma in children with chronic rhinosinusitis

9. The -463G/A and -129G/A Myeloperoxidase-Encoding Gene Polymorphism in Chronic Obstructive Pulmonary Disease

10. Artificial neural network identifies nonsteroidal anti‐inflammatory drugs exacerbated respiratory disease (N‐ERD) cohort

13. High levels of anxiety during the COVID-19 pandemic as a risk factor of clinical worsening in patients with severe asthma

14. Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions

15. Mental health indices may fully mediate the relationship between morningness-eveningness and disease control among adult asthma patients

16. 3TR

17. COEXISTENCE OF PULMONARY FIBROSIS AND PROLIFERATION OF PULMONARY NEUROENDOCRINE CELLS FORMING TUMORLET

18. ARIA-Versorgungspfade für die Allergenimmuntherapie 2019

19. Produkty tytoniowe oparte na podgrzewaniu tytoniu (heat-not-burn) a zdrowie pacjentów — opinia grupy ekspertów

20. Endoplasmic reticulum aminopeptidase 1 polymorphism Ile276Met is associated with atopic dermatitis and affects the generation of an <scp>HLA</scp> ‐C associated antigenic epitope in vitro

21. Bronchial asthma control degree and the temperament structure according to the Eysenck model

22. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma

23. 2019 ARIA – Care pathways for allergic rhinitis – Poland

24. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases -Meeting Report (Part 1)

25. Reductions in Inflammatory Biomarkers in Patients with Oral Corticosteroid-Dependent Asthma Treated with Tezepelumab

26. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model

27. Contribution of Antigen-Processing Machinery Genetic Polymorphisms to Atopic Dermatitis

28. Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms

29. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA

30. Expression of cPLA2γ mRNA and protein differs the response of PBMC from severe and non-severe asthmatics to bacterial lipopolysaccharide and house dust mite allergen

31. Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19

32. Expression of Transcript Variants of PTGS1 and PTGS2 Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps

33. Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases

34. Home self-monitoring in patients with asthma using a mobile spirometry system

35. Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease

36. A severity grading system of food-induced acute allergic reactions to avoid the delay of epinephrine administration

37. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. a MASK study

39. Benralizumab for the Prevention of COPD Exacerbations

40. Primary non-adherence to inhaled medications measured with e-prescription data from Poland

41. Comparison of a dry powder inhaler (DPI) to a pressurized metered-dose inhaler (pMDI) formulation of extra fine beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) in patients with COPD: The TRI-D study

42. Allergic diseases in patients with sarcoidosis- data from a tertiary pulmonary center

43. Any role for cardiopulmonary exercise test as an outcome in severe asthmatic patients after the initiation of biological therapy?

44. Biological Therapies of Severe Asthma and Their Possible Effects on Airway Remodeling

45. Primary Non-Adherence to Antihistamines—Conclusions From E-Prescription Pilot Data in Poland

46. Effectiveness of beclometasone dipropionate and formoterol in an extrafine particle formulation for asthma therapy depending on patient smoking status: the CASPER noninterventional, observational trial

47. Role of Platelet-Derived Growth Factor (PDGF) in Asthma as an Immunoregulatory Factor Mediating Airway Remodeling and Possible Pharmacological Target

48. ARIA���EAACI statement on asthma and COVID���19 (June 2, 2020)

49. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden

50. The effect of levocetirizine and montelukast on clinical symptoms, serum level and skin expression of COX-1 and COX-2 enzymes in patients suffering from chronic autoimmune urticaria – a pilot study

Catalog

Books, media, physical & digital resources